Natural history of prostate cancer - Epidemiologic considerations

Epidemiologic Reviews

Volumn 23, Issue 1, 2001, Pages 14-18

  Miller, Gary J ^a   Torkko, Kathleen C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER STAGING; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0034810824     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000780     Document Type: Review

References (52)

1. Prostate
2. An anatomic and histologic study of the rat prostate
3. Prostate development in prune belly syndrome (PBS) and posterior urethral valves (PUV): Etiology of PBS - Lower urinary tract obstruction or primary mesenchymal defect?
4. The development of the reproductive system
5. Anatomy of the prostate and morphogenesis of BPH
6. The association of benign prostatic hyperplasia and cancer of the prostate
7. An atlas of prostate biopsies - Dilemmas of morphologic variance
8. The utility of basal cell-specific anti-cytokeratin antibody (34βE12) in the diagnosis of prostate cancer: A review of 228 cases
9. Intraductal dysplasia: A premalignant lesion of the prostate
10. Atypical adenomatous hyperplasia of the prostate: A premalignant lesion?
11. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia
12. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic carcinoma
13. Prostatic intraepithelial neoplasia is a risk factor for cancer
14. Microcarcinoma in the prostate: Its association with duct-acinar dysplasia
15. Allelic loss in locally metastatic, multisampled prostate cancer
16. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
17. Molecular analysis of multifocal prostate cancer lesions
18. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate
19. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer
20. Screening for prostate cancer with prostate-specific antigen: An examination of the evidence
21. Comparison of percent free PSA, PSA density, and age-specific PSA cut-offs for prostate cancer detection and staging
22. Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays
23. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
24. Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield
25. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
26. Morphology of prostate cancer: The effects of multifocality on histologic grade, tumor volume and capsule penetration
27. Prostate
28. Adenocarcinoma of the prostate: Innovations in management
29. Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy
30. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update
31. Histologic grading and staging of prostate carcinoma
32. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer
33. The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c,2a: Implications for patient selection for prostate-only therapy
34. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens
35. Histologic grading of prostate cancer: A perspective
36. Accuracy of biopsy Gleason scores from a large uropathology laboratory: Use of a diagnostic protocol to minimize observer variability
37. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: Accuracy and clinical implications
38. Predictive accuracy of transrectal ultrasound-guided prostate biopsy: Correlations to matched prostatectomy specimens
39. International trends and patterns of prostate cancer incidence and mortality
40. Migration and prostate cancer: An international perspective
41. Increased incidence of prostate cancer in Nigerians
42. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease
43. Race and cause specific survival with prostate cancer: Influence of clinical stage, Gleason score, age and treatment
44. Comparison of ras activation in prostate carcinoma in Japanese and American men
45. Geographic pathology of latent prostatic carcinoma
46. Prostate cancer among the Chinese: Pathologic, epidemiologic and nutritional considerations
47. Observations on the doubling time of prostate cancer
48. Morphological analysis and classification of latent prostate cancer using a 3-dimensional computer algorithm: Analysis of tumor volume, grade, tumor doubling time and life expectancy
49. Molecular markers for prostate cancer metastasis
50. Oncogenes in prostate cancer: An update
51. Rapid microwave-stimulated fixation of entire prostatectomy specimens
52. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue